Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Fevertree Drinks ( (GB:FEVR) ).
Fever-Tree announced that Kevin Havelock, the Senior Independent Non-Executive Director, purchased 55,000 ordinary shares in the company at an average price of GBP 8.68 per share via the London Stock Exchange. This transaction reflects confidence in the company’s market position and future prospects, potentially signaling positive sentiment to investors and stakeholders.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £959.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Spark’s Take on GB:FEVR Stock
According to Spark, TipRanks’ AI Analyst, GB:FEVR is a Neutral.
Fevertree Drinks’ overall stock score is primarily supported by its strong financial performance, characterized by robust cash flow and a solid balance sheet. However, the high P/E ratio raises valuation concerns, and technical indicators suggest a neutral market sentiment. The absence of recent earnings call insights or notable corporate events limits additional context for the stock’s outlook.
To see Spark’s full report on GB:FEVR stock, click here.
More about Fevertree Drinks
Fever-Tree is the world’s leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 90 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high-quality mixers catering to the growing demand for premium spirits, particularly gin, as well as vodka, rum, and whisky. The company sells a range of carbonated mixers to hotels, restaurants, bars, cafes, and selected retail outlets.
YTD Price Performance: 31.82%
Average Trading Volume: 459,396
Technical Sentiment Signal: Sell
Current Market Cap: £1.02B
For detailed information about FEVR stock, go to TipRanks’ Stock Analysis page.

